# The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease

> **NCT01277237** · PHASE3 · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 50 (actual)

## Conditions studied

- Non Alcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Omacor
- **DRUG:** lactose tablet

## Key facts

- **NCT ID:** NCT01277237
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01277237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01277237, "The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01277237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*